RS20070461A - Injektibilne kompozicije i postupak za njihovo dobijanje - Google Patents

Injektibilne kompozicije i postupak za njihovo dobijanje

Info

Publication number
RS20070461A
RS20070461A RSP-2007/0461A RSP20070461A RS20070461A RS 20070461 A RS20070461 A RS 20070461A RS P20070461 A RSP20070461 A RS P20070461A RS 20070461 A RS20070461 A RS 20070461A
Authority
RS
Serbia
Prior art keywords
composition according
cox
agents
mixture
inhibitor
Prior art date
Application number
RSP-2007/0461A
Other languages
English (en)
Serbian (sr)
Inventor
Rajesh JAIN
Kour Chand JINDAL
Sukhjeet Singh
Sanjay Boldhane
Original Assignee
Panacea Biotec Ltd.,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Panacea Biotec Ltd., filed Critical Panacea Biotec Ltd.,
Publication of RS20070461A publication Critical patent/RS20070461A/sr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/405Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
RSP-2007/0461A 2005-05-27 2006-05-25 Injektibilne kompozicije i postupak za njihovo dobijanje RS20070461A (sr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1357DE2005 2005-05-27
PCT/IN2006/000177 WO2006126214A2 (en) 2005-05-27 2006-05-25 Injectable compositions and process for preparation of such compositions

Publications (1)

Publication Number Publication Date
RS20070461A true RS20070461A (sr) 2008-11-28

Family

ID=36917368

Family Applications (1)

Application Number Title Priority Date Filing Date
RSP-2007/0461A RS20070461A (sr) 2005-05-27 2006-05-25 Injektibilne kompozicije i postupak za njihovo dobijanje

Country Status (15)

Country Link
EP (1) EP1895983A2 (es)
JP (1) JP2008542260A (es)
KR (1) KR20080016689A (es)
CN (1) CN101217939A (es)
AU (1) AU2006250765A1 (es)
BR (1) BRPI0611170A2 (es)
CA (1) CA2609242A1 (es)
CR (1) CR9616A (es)
EA (1) EA200702646A1 (es)
MX (1) MX2007014862A (es)
NO (1) NO20076468L (es)
RS (1) RS20070461A (es)
TN (1) TNSN07482A1 (es)
WO (1) WO2006126214A2 (es)
ZA (1) ZA200711068B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2698721A1 (en) 2007-09-07 2009-03-12 United Therapeutics Corporation Buffer solutions having selective bactericidal activity against gram negative bacteria and methods of using same
AU2010224063B2 (en) 2009-03-12 2015-04-16 Cumberland Pharmaceuticals Inc Administration of intravenous ibuprofen
US8871810B2 (en) 2009-07-15 2014-10-28 Cumberland Pharmaceuticals Inc. Treating critically ill patients with intravenous ibuprofen
CN102335114B (zh) * 2010-07-23 2015-07-15 重庆医药工业研究院有限责任公司 一种稳定的布洛芬精氨酸注射剂及其制备方法
CN102370615B (zh) * 2010-08-19 2013-09-04 四川科伦药物研究有限公司 一种布洛芬注射制剂及其制备方法
US9447065B2 (en) 2011-10-18 2016-09-20 Raqualia Pharma Inc. Pharmaceutical composition
CN102512383A (zh) * 2011-12-25 2012-06-27 天津市嵩锐医药科技有限公司 供注射用的帕瑞昔布钠药物组合物
US9072710B2 (en) 2012-03-16 2015-07-07 Cumberland Pharmaceuticals Inc. Injectable ibuprofen formulation
CN103372216B (zh) * 2012-04-26 2015-05-06 北京京卫燕康药物研究所有限公司 一种含有塞来昔布的固体药物组合物
US20140187635A1 (en) * 2012-12-28 2014-07-03 Themis Medicare Limited Diclofenac compositions
TWI646091B (zh) 2012-12-28 2019-01-01 日商衛斯克慧特股份有限公司 鹽類及晶形
US20140275261A1 (en) 2013-03-15 2014-09-18 Dr. Reddy's Laboratories, Inc. Diclofenac parenteral compositions
CN103263385B (zh) * 2013-05-17 2016-04-27 江苏正大清江制药有限公司 一种塞来昔布长效纳米注射剂及其制备方法
TN2017000232A1 (en) * 2014-12-20 2018-10-19 Troikaa Pharmaceuticals Ltd Injectable formulations of paracetamol
WO2016170401A1 (en) * 2015-04-20 2016-10-27 Umedica Laboratories Pvt. Ltd Novel injectable composition of diclofenac sodium
CN107303266B (zh) * 2016-04-18 2020-09-08 重庆润泽医药有限公司 左旋奥拉西坦注射液及其制备方法
CN107303264A (zh) * 2016-04-18 2017-10-31 重庆润泽医药有限公司 无泡沫左旋奥拉西坦注射液及其制备方法
FR3077984B1 (fr) * 2018-02-16 2020-02-21 Vetoquinol Sa Composition multiusage de torasemide
CN109498852B (zh) * 2018-12-29 2022-06-24 广州噢斯荣医药技术有限公司 治疗骨科疾病的生物降解材料及其应用
CN111103381A (zh) * 2019-12-25 2020-05-05 南京希麦迪医药科技有限公司 一种液质联用测定人血浆中尼美舒利浓度的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5389681A (en) * 1992-10-22 1995-02-14 Ciba-Geigy Corporation Parenteral solutions for diclofenac salts
IT1283252B1 (it) * 1996-03-15 1998-04-16 Pulitzer Italiana Soluzioni di piroxicam iniettabili per via parenterale
IN187306B (es) * 1998-01-12 2002-03-23 Panacea Biotec Ltd
MY137736A (en) * 2001-04-03 2009-03-31 Pharmacia Corp Reconstitutable parenteral composition
AU2003249510A1 (en) * 2002-08-12 2004-02-25 Ranbaxy Laboratories Limited A parenteral dosage form of selective cox-2 inhibitors

Also Published As

Publication number Publication date
TNSN07482A1 (fr) 2009-03-17
KR20080016689A (ko) 2008-02-21
EA200702646A1 (ru) 2008-06-30
MX2007014862A (es) 2008-02-21
EP1895983A2 (en) 2008-03-12
ZA200711068B (en) 2009-03-25
WO2006126214A2 (en) 2006-11-30
AU2006250765A1 (en) 2006-11-30
JP2008542260A (ja) 2008-11-27
NO20076468L (no) 2008-02-27
CN101217939A (zh) 2008-07-09
WO2006126214A3 (en) 2007-06-07
CA2609242A1 (en) 2006-11-30
BRPI0611170A2 (pt) 2010-08-17
CR9616A (es) 2008-10-30

Similar Documents

Publication Publication Date Title
RS20070461A (sr) Injektibilne kompozicije i postupak za njihovo dobijanje
FR2853547A1 (fr) Compositions pharmaceutiques injectables contenant de la piperacilline et du tazobactame, et procede pour leur production
CN104302176B (zh) 可注射布洛芬制剂
CN101208081A (zh) 治疗疼痛的方法和组合物
ITMI981795A1 (it) Composizione farmaceutica iniettabile a base di paracetamolo
CZ297788B6 (cs) Farmaceutický prostredek pro parenterální podání
WO2011111070A2 (en) Novel injectable combination
AU2006221633B2 (en) Injectable preparations of diclofenac and its pharmaceutically acceptable salts
KR20070059154A (ko) 비수계의 액상 비경구 아세클로페낙 제제
JP3917820B2 (ja) オザグレルナトリウム含有注射液およびその安定化方法
WO2017037232A1 (en) Anidulafungin formulations
RS49608B (sr) Stabilizovane farmaceutske smeše na bazi hinupristina i dalfopristina i njihovo dobivanje
US11382871B2 (en) Pharmaceutical composition containing curcumin
WO2012120337A1 (en) Aqueous paracetamol compositions and method of preparation
WO2017198224A1 (zh) 一种瑞马唑仑的药物组合物
HK1119574A (en) Injectable compositions and process for preparation of such compositions
JP2022036050A (ja) ロキソプロフェン配合皮膚外用剤
EP4076442A1 (en) Pharmaceutical composition of cyclooxygenase - 2 inhibitors
KR102427941B1 (ko) 이부프로펜 및 아르기닌을 함유하는 안정성이 개선된 주사용 제제
WO2019130228A1 (en) Stable liquid compositions of melphalan
JP2007045788A (ja) グリチルリチン酸高濃度水溶液の調製法
AU2025223868A1 (en) Pemetrexed formulations
CN118510496A (zh) 含有异𫫇唑啉衍生物的注射制剂
US20160144033A1 (en) Concentrated acetaminophen solution
US20150141518A1 (en) Water-miscible stable solution composition for pharmaceutically active ingredients that are poorly soluble in water and susceptible to chemical degradation